Superior Group Q3 Net Sales Rise 5% to $146M, EPS Flat at $0.17

Superior Group of Companies, Inc. (NASDAQ: SGC) reported third-quarter 2026 net sales of $146.0 million on 9 November 2026, up 5% from $138.5 million a year earlier, while net income slipped to $2.6 million from $2.7 million and diluted earnings per share held at $0.17 versus $0.18. Adjusted EBITDA fell to $6.7 million from $7.5 million. The company tightened its full-year 2026 net sales guidance to a range of $578.0 million to $585.0 million and adjusted diluted EPS to $0.60 to $0.66.

Context — Why Superior Group's Flat Q3 EPS Matters Now

The quarter lands against a company that has been repositioning its Healthcare Apparel segment under new leadership. Chief Executive Officer Michael Benstock said the unit is executing toward a more focused product strategy aimed at improving margins and reducing working capital requirements in the quarters ahead. That repositioning carried incremental charges in the quarter, which the company said it absorbed while holding EPS essentially flat year over year.

The prior-year comparison is unflattering on the profitability line. Net income declined year over year even as the top line grew, and adjusted EBITDA compressed by $0.8 million. The gap between revenue growth and earnings performance is the central tension in the release.

Superior Group operates three segments — Healthcare Apparel, Branded Products and Contact Centers — each serving what the company describes as large, fragmented and growing addressable markets. The mix shift within those segments is doing more work on the earnings line than the headline sales figure suggests.

On a nine-month basis, net sales reached $434.7 million versus $419.6 million in the prior-year period, a 3.6% increase. Net income for the nine months was $4.6 million compared with $3.5 million, though the 2026 figure absorbed a $2.6 million trade name impairment charge recorded earlier in the year.

The company also pointed to its recent acquisition of Select VoiceCom and the return of capital to shareholders as elements of its capital allocation posture. The report did not disclose the terms of that acquisition.

Data — What Superior Group's Q3 Numbers Show

The headline figures: net sales of $146.0 million versus $138.5 million; net income of $2.6 million versus $2.7 million; diluted EPS of $0.17 versus $0.18; adjusted EBITDA of $6.7 million versus $7.5 million. Nine-month net sales were $434.7 million against $419.6 million.

Metric	Q3 2026	Q3 2025
Net sales	$146.0M	$138.5M
Net income	$2.6M	$2.7M
Diluted EPS	$0.17	$0.18
Adjusted EBITDA	$6.7M	$7.5M

Segment detail explains the divergence. Branded Products net sales rose to $92.1 million from $85.1 million, and its segment adjusted EBITDA climbed to $9.8 million from $7.5 million. Contact Centers net sales rose to $24.2 million from $22.7 million, with segment adjusted EBITDA up to $2.9 million from $2.4 million.

Healthcare Apparel moved the other way. Net sales fell to $30.6 million from $31.5 million, and segment adjusted EBITDA swung to a loss of $0.5 million from positive $3.2 million a year earlier. That single segment accounts for the consolidated EBITDA decline.

Corporate selling and administrative expenses were $5.6 million in the quarter. Cash and cash equivalents stood at $27.9 million at 30 September 2026, up from $23.7 million at 31 December 2025, while total long-term debt fell to $74.3 million from $87.1 million.

Analysis — What It Means for SGC and Apparel Peers

The second-order read is that Superior Group's growth is being carried by Branded Products and Contact Centers while Healthcare Apparel absorbs the cost of repositioning. Investors tracking uniform and service-apparel names should watch whether the Healthcare Apparel loss is a transitional trough or a structural margin problem, because the segment's swing of roughly $3.7 million in adjusted EBITDA is larger than the consolidated decline.

Working capital is moving in the right direction. Inventories fell to $87.9 million from $97.5 million at year-end 2025, and accounts receivable declined to $96.3 million from $104.3 million. The nine-month cash flow statement shows $30.7 million provided by operating activities versus $1.3 million a year earlier, aided partly by $9.5 million in inventory write-downs.

The counter-argument is that the operating cash flow improvement leans on non-cash charges and working capital release rather than earnings power. Inventory write-downs of $9.5 million and credit loss expense of $3.2 million are real economic costs even if they do not hit the current-period cash line. A reader should weigh whether the balance-sheet improvement is repeatable.

On positioning, the company repurchased $1.5 million of common shares in the nine months, down sharply from $7.9 million a year earlier, and paid $6.6 million in dividends. The reduced buyback pace alongside the Select VoiceCom acquisition suggests capital is rotating toward inorganic growth.

Outlook — What to Watch Next for Superior Group

The company tightened full-year 2026 net sales guidance to $578.0 million to $585.0 million, from a prior range of $572.0 million to $585.0 million, against 2025 net sales of $566.2 million. It tightened adjusted diluted EPS guidance to $0.60 to $0.66 from $0.54 to $0.66, against $0.46 in 2025 — which the company said represents 43% growth at the high end.

The company hosted a webcast and conference call at 8:00am Eastern Time on 9 November 2026. A telephone replay is available through 23 November 2026, referencing conference number 8522694. Investors seeking segment-level color on Healthcare Apparel's margin trajectory will find it in that call rather than in the release.

The main catalyst to watch is whether Healthcare Apparel returns to positive segment adjusted EBITDA before year-end, since the full-year EPS range depends on that recovery. The report did not break out fourth-quarter assumptions. The company's stated expectation of finishing the year with growth in both sales and earnings compared to 2025 is a forward-looking statement subject to the risks it lists, including tariff and supply-chain uncertainty.

Frequently Asked Questions

Why did Superior Group's net income fall while sales rose?

Net income slipped to $2.6 million from $2.7 million even as net sales rose 5%, because the Healthcare Apparel segment swung to an adjusted EBITDA loss of $0.5 million from positive $3.2 million. That roughly $3.7 million segment-level decline more than offset the combined gains in Branded Products and Contact Centers, and the company cited incremental charges tied to its strategic shift in Healthcare Apparel.

What is Superior Group's full-year 2026 earnings guidance?

The company tightened its 2026 adjusted diluted EPS forecast to $0.60 to $0.66, from a previous range of $0.54 to $0.66, compared with $0.46 in 2025. At the high end that represents 43% growth. Net sales guidance was tightened to $578.0 million to $585.0 million from $572.0 million to $585.0 million, against 2025 net sales of $566.2 million.

What is the Select VoiceCom acquisition?

Superior Group referenced its recent acquisition of Select VoiceCom in the CEO's comments as an example of continued strategic investment, alongside returning capital to shareholders. The report did not disclose the purchase price, the closing date, or Select VoiceCom's financial contribution. Select VoiceCom is expected to sit within the company's Contact Centers segment, though the release did not confirm segment placement.

Bottom Line

Superior Group grew sales 5% but leaned entirely on Branded Products and Contact Centers, leaving Healthcare Apparel's recovery as the swing factor for its tightened full-year guidance.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.